West Pharmaceutical Services Inc Net Income per Employee (WST), current and historic results, rankings and more, Quarterly Fundamentals - CSIMarket
CSIMarket
 


West Pharmaceutical Services Inc   (NYSE: WST)
 

West Pharmaceutical Services Inc Net Income per Employee

WST's Quarterly Results, Trends, Rankings, Statistics
With an income increase of 16.84% in the second quarter 2026, year on year to cumulative value of $565 million, and with 10,800 employees, West Pharmaceutical Services Inc 's income per employee grew on trailing twelve month basis to $ 52,306. The income per employee at West Pharmaceutical Services Inc ' was above the company average.
The Healthcare sector has seen employees of 29 other companies achieving higher income per employee. While income per employee total ranking has improved so far to 1355, from total ranking in previous quarter at 1621.


What is Income per Employee Ratio?






WST Net Income per Employee (Jun 30 2026)
II. Quarter
(Mar 31 2026)
I. Quarter
(Dec 31 2025)
IV. Quarter
(Sep 30 2025)
III. Quarter
(Jun 30 2025)
II. Quarter
Y / Y Net Income Change 16.84 % 54.57 % 1.54 % 2.94 % 18.42 %
Net Income per Employee (TTM) $ 52,306 50,250 45,713 45,528 45,157
WST's Total Ranking # 1355 # 1621 # 1424 # 1405 # 1405
Seq. Net Income Change 10.95 % 5.07 % -5.64 % 6.22 % 46.77 %


WST Net Income per Employee Company Ranking
Within: No.
Medical Equipment & Supplies Industry # 30
Healthcare Sector # 122
Overall Market # 1355

Net Income per Employee Statistics
High Average Low
$ 63,481 $ 29,873 $ 5,796
(Jun 30 2022)   (Sep 30 2011)







Companies with similar Income per Employee for 12 month ending Jun 30 2026, within Healthcare Sector Income per Employee Income 12 month ending Jun 30 2026Number of Employees Jun 30 2026
Protalix Biotherapeutics inc   83,827.43 $ 18.945  Million 226 
Agilent Technologies inc   79,558.01 $ 1,440.000  Million 18,100 
Alpha Pro Tech Ltd   79,325.20 $ 9.757  Million 123 
Medpace Holdings Inc   79,274.19 $ 491.500  Million 6,200 
Aveanna Healthcare Holdings Inc   78,503.43 $ 274.762  Million 3,500 
Corcept Therapeutics Inc  74,261.64 $ 54.211  Million 730 
Strata Critical Medical Inc   66,923.46 $ 40.221  Million 601 
Stryker Corp  66,589.29 $ 3,729.000  Million 56,000 
Pro dex Inc   66,320.39 $ 13.662  Million 206 
Edwards Lifesciences Corporation  62,725.00 $ 1,003.600  Million 16,000 
Bio techne Corp  60,620.67 $ 181.862  Million 3,000 
Msa Safety Inc  59,246.98 $ 314.009  Million 5,300 
Pfizer Inc  58,266.67 $ 4,370.000  Million 75,000 
Sbc Medical Group Holdings Incorporated  57,479.19 $ 49.605  Million 863 
Electromed Inc   57,365.48 $ 11.301  Million 197 
Utah Medical Products Inc  57,300.55 $ 10.486  Million 183 
Medtronic Plc  55,463.16 $ 5,269.000  Million 95,000 
Mettler toledo International Inc   54,554.88 $ 905.611  Million 16,600 
West Pharmaceutical Services Inc   52,305.56 $ 564.900  Million 10,800 
3m Company  49,785.12 $ 3,012.000  Million 60,500 
Nephros Inc   48,222.22 $ 1.736  Million 36 
Cormedix Inc   47,794.66 $ 9.129  Million 191 
Embecta Corp   47,297.30 $ 87.500  Million 1,850 
Qhslab Inc   43,675.67 $ 0.524  Million 12 
Merck and Co Inc   42,266.67 $ 3,170.000  Million 75,000 
Phibro Animal Health Corporation  38,280.23 $ 99.720  Million 2,605 
Arvinas Inc   37,804.88 $ 9.300  Million 246 
Alkermes Plc   32,255.12 $ 66.123  Million 2,050 
Tenet Healthcare Corp  32,060.61 $ 3,174.000  Million 99,000 
Pacific Health Care Organization Inc  31,571.29 $ 0.979  Million 31 


Date modified: 2026-07-24T15:19:30+00:00




Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.